Cargando…
What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT
BACKGROUND: Multiple Sclerosis (MS) is a chronic neurological disorder caused by neurodegeneration within the central nervous system. It results in impaired physical, cognitive, and psychological functioning and can also lead to lower urinary tract symptoms including nocturia. While clinical trials...
Autores principales: | Khan, Rafiyah, Uren, Alan, Canham, Luke, Cottrell, David, Drake, Marcus J., Cotterill, Nikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211202/ https://www.ncbi.nlm.nih.gov/pubmed/30420919 http://dx.doi.org/10.1155/2018/4721505 |
Ejemplares similares
-
Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)
por: Drake, Marcus J., et al.
Publicado: (2018) -
Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS)
por: Delgado, D., et al.
Publicado: (2017) -
A practical approach to the management of nocturia
por: Oelke, Matthias, et al.
Publicado: (2017) -
The impact of melatonin on the sleep patterns of women undergoing IVF: a double blind RCT
por: Fernando, Shavi, et al.
Publicado: (2018) -
Pharmacotherapy for Nocturia
por: Andersson, Karl-Erik, et al.
Publicado: (2018)